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Abstract. 
 
Shiga toxin and other toxins of this family 
can escape the endocytic pathway and reach the Golgi 
apparatus. To synchronize endosome to Golgi trans-
port, Shiga toxin B-fragment was internalized into 
HeLa cells at low temperatures. Under these condi-
tions, the protein partitioned away from markers des-
tined for the late endocytic pathway and colocalized ex-
tensively with cointernalized transferrin. Upon 
 
subsequent incubation at 37
 
8
 
C, ultrastructural studies 
on cryosections failed to detect B-fragmentÐspecific la-
bel in multivesicular or multilamellar late endosomes, 
suggesting that the protein bypassed the late endocytic 
pathway on its way to the Golgi apparatus. This hy-
pothesis was further supported by the rapid kinetics of 
B-fragment transport, as determined by quantitative 
confocal microscopy on living cells and by B-fragment 
sulfation analysis, and by the observation that actin-
depolymerizing and pH-neutralizing drugs that modu-
late vesicular transport in the late endocytic pathway 
had no effect on B-fragment accumulation in the Golgi 
apparatus. B-fragment sorting at the level of early/recy-
cling endosomes seemed to involve vesicular coats, 
since brefeldin A treatment led to B-fragment accumu-
lation in transferrin receptorÐcontaining membrane tu-
bules, and since B-fragment colocalized with adaptor 
protein type 1 clathrin coat components on early/recy-
cling endosomes. Thus, we hypothesize that Shiga toxin 
B-fragment is transported directly from early/recycling 
endosomes to the Golgi apparatus. This pathway may 
also be used by cellular proteins, as deduced from our 
finding that TGN38 colocalized with the B-fragment on 
its transport from the plasma membrane to the TGN.
Key words: Shiga toxin ¥ endosomes ¥ Golgi ¥ intra-
cellular transport ¥ clathrin
 
B
 
acterial
 
 and plant protein toxins use functions of
higher eucaryotic cells for the transduction of their
activity (OÕBrien et al., 1992; Sandvig and van
Deurs, 1996). For example, they rely on intracellular trans-
port to reach their target molecules that often reside in the
cytoplasm. Toxins such as diphtheria toxin are endocy-
tosed and then cross membranes at the level of endosomes
in a pH-dependent process. Other toxins such as Shiga
toxin, verotoxins, Cholera toxin, and ricin do not depend
on acidic pH in endosomes for intoxication of cells.
Rather, these toxins are sensitive to treatments that affect
the biosynthetic/secretory pathway suggesting that mem-
brane transfer occurs at the level of the Golgi apparatus or
 
the ER that these toxins have to reach by retrograde trans-
port from the plasma membrane (Pelham et al., 1992). Es-
pecially toxins of the latter group are thus interesting mod-
els to study transport routes in animal cells that to date are
still little explored.
Shiga toxin and the virtually identical VT-1 are pro-
duced by 
 
Shigella dysenteriae
 
 and by certain enterohemor-
rhagic strains of 
 
Escherichia coli
 
, respectively (OÕBrien et al.,
1992; Sandvig and van Deurs, 1996; Johannes and Goud,
1998). These toxins have been identified as the etiologic
agents of the hemolytic and uremic syndrome and of hem-
orrhagic colitis (OÕBrien et al., 1992; Lingwood, 1996).
They are composed of a catalytically active A-subunit and
a receptor binding B-subunit. The A-subunit, a 
 
N
 
-glycosi-
dase that inhibits protein synthesis through the modifica-
tion of 28S rRNA, depends upon a noncovalent interac-
tion with the B-subunit for its binding to target cells and its
intracellular transport. The B-subunit is a homopentamer
of B-fragments that form a symmetrical ring-like structure
in solution. The B-subunit binds with high affinity to the
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cellular toxin receptor, the glycolipid globotriaosylceramid
(Lingwood, 1993). The toxinÐreceptor complex is then in-
ternalized, likely via clathrin-dependent mechanisms (Sand-
vig et al., 1989). In many cancer cell lines, internalized
toxin or B-subunit is transported from endosomes via the
TGN/Golgi apparatus to the ER (Sandvig et al., 1992,
1994; Johannes et al., 1997; Kim et al., 1998). The mecha-
nisms of this retrograde transport remain elusive.
Notably, the precise site at which Shiga toxin leaves en-
dosomes to target the TGN/Golgi apparatus is still un-
known. The existence of two potential transport routes be-
tween endosomes and the TGN has been suggested
because of the identification of proteins that are common
to both compartments (for reviews see Gruenberg and
Maxfield, 1995; Mellman, 1996; Mukherjee et al., 1997). A
direct transport route from late endosomes (LE)
 
1
 
 to the
TGN has been hypothesized for the cation-independent
mannose 6-phosphate receptor (CI-MPR) and the MPR of
46 kD (MPR46), which both bind mannose 6-phosphateÐ
tagged proteins at the level of the TGN and deliver these
proteins to LE (von Figura, 1991; Munier-Lehmann et al.,
1996). MPRs can also be found to a lesser extent in the
plasma membrane and early endosomes (EE). Ligand dis-
sociation occurs at low pH of LE, from where uncharged
receptors are transported back to the TGN in a reaction
regulated by the small GTP-binding protein Rab9 (Lom-
bardi et al., 1993; Riederer et al., 1994). Based on the find-
ing that small quantities of a marker protein for EE and
recycling endosomes (RE), transferrin (Tf), can be de-
tected in the TGN (Fishman and Fine, 1987; Stoorvogel
et al., 1988), the existence of a direct transport route from
EE/RE to the TGN has been hypothesized. Two other
proteins that have been studied in some detail are TGN38
and the protease furin (Humphrey et al., 1993; Reaves et al.,
1993; Chapman and Munro, 1994; Molloy et al., 1994; Pon-
nambalam et al., 1994). At steady-state, both are concen-
trated in the TGN. However, both proteins are also found
in the plasma membrane and endosomes, and antibodies
directed to these proteins are transported from the plasma
membrane to the TGN. The itinerary of these proteins
from endosomes to the TGN is still unknown.
In this study we have investigated the transport route
taken by Shiga toxin B-fragment from EE to the Golgi ap-
paratus. We found that the B-fragment accumulated with
Tf in EE/RE when incubated with HeLa cells at 19.5
 
8
 
C.
From this compartment, the B-fragment was rapidly trans-
ported to the TGN/Golgi apparatus, without apparent pas-
sage via LE. Our immunolocalization studies suggest that
B-fragment sorting at the level of EE/RE involves adaptor
protein type 1 (AP-1) clathrin coats. We thus hypothesize
the existence of a direct transport route between EE/RE
and the Golgi apparatus, which may also be used by cellu-
lar proteins, as judged from the finding that TGN38 colo-
calized with B-fragment during transport to the TGN.
 
Materials and Methods
 
Cells
 
HeLa cells were grown in DME containing 4.5 g/liter glucose (GIBCO
BRL, Gaithersburg, MD) supplemented with 10% FCS (GIBCO BRL),
0.01% penicillin/streptomycin, 4 mM glutamine, and 5 mM pyruvate in a
5% CO
 
2
 
 incubator.
 
Reagents and Antibodies
 
Cy3, iodine, radioactive sulfate, and radiolabeled EGF (Amersham Life
Science, Inc., Arlington Heights, IL), iodobeads, Tf-HRP, and FITC
(Pierce Chemical Co., Rockford, IL), 5-([4,6-dichlorotriazin-2-yl]amino)
fluorescein, ferro-Tf, CytoD, and Noc (Sigma, Saint-Quentin-Fallavier,
France), Bafi (Fluka, Saint-Quentin-Fallavier, France), BFA (Epicentre
Technologies Corp., Madison, WI), FITC-labeled Dex3, and tetramethyl-
rhodamine-labeled EGF (Molecular Probes, Inc., Eugene, OR) were pur-
chased from the indicated commercial sources. The antiÐB-fragment mAb
13C4 was purified as described (Johannes et al., 1997). The anti-transfer-
rin receptor mAb H68.4, the CTR433 mAb, the antiÐrat TGN38 mAb
2-F7-1, the antiÐ
 
g
 
-adaptin mAb 100/3, the anti-clathrin mAb X-22, the
polyclonal antiÐB-fragment antibody, the polyclonal antiÐCI-MPR anti-
body, and the polyclonal anti-MPR46 antibody (MSC1, antiÐcytoplasmic
tail) were provided by I. Trowbridge (The Salk Institute, San Diego, CA),
M. Bornens (Institut Curie, Paris, France), G. Banting (University of Bris-
tol, Bristol, UK), E. Ungewickell (Max-Planck-Institut, Martinsried, Ger-
many), F. Brotsky (University of California, San Francisco, CA), K. Nie-
buhr-Ebel (Institut Pasteur, Paris, France), B. Hoflack (Institut Pasteur,
Lille, France), and K. von Figura (Universitt Gttingen, Gttingen, Ger-
many), respectively. The polyclonal anti-FITC antibody, the polyclonal
anti-HRP antibody, and FITC- or Texas redÐcoupled secondary antibod-
ies were purchased from Molecular Probes, Inc., Sigma, and Jackson Im-
munoResearch Labs, Inc. (West Grove, PA), respectively.
 
Plasmids
 
To construct a plasmid expressing a mutant B-fragment carrying a tandem
of sulfation sites at its COOH terminus (termed B-(Sulf)
 
2
 
), a previously
described PCR-based strategy was adopted (Johannes et al., 1997). First,
expression vector pSU108 was modified to introduce EcoRI and NotI re-
striction sites at the 3
 
9
 
 end of B-fragment cDNA (pB-EcoRI-NotI). PCR
primers EN1 (5
 
9
 
-ACTAGCTCTGAAAAGCGGCCGCTAATGACTC-
AGAATAGCTC-3
 
9
 
) and EN2 (5
 
9
 
-CCGCTTTTCAGAGCTAGTGAA-
TTCACGAAAAATAACTTCGC-3
 
9
 
) were used with plasmid-specific
primers ShigaAtpE (5
 
9
 
-CACTACTACGTTTTAAC-3
 
9
 
) and Shiga-fd
(5
 
9
 
-CGGCGCAACTATCGG-3
 
9
 
) to produce DNA fragments that, in a
second PCR with primers ShigaAtpE and Shiga-fd, yielded a fragment
that was cloned into the SphI and SalI restriction sites of pSU108. After
polymerization cycles with sulfation site carrying oligodeoxynucleotides
S1 (5
 
9
 
-TATGAATTCGAGGAACCTGAGTATGGAGAAGAGGAA-
CCTGAGTATGG-3
 
9
 
) and S2 (5
 
9
 
-GCTACTTTTTTGCGGCCGCTTT-
CTCCATACTCAGGTTCCTCTTC-3
 
9
 
), the resulting fragment was
cloned into the EcoRI and NotI restriction sites of pB-EcoRI-NotI. Se-
quences derived by PCR were verified by dideoxy-sequencing (Amer-
sham Pharmacia Biotech, Uppsala, Sweden).
 
Purification and Labeling of Recombinant B-fragments 
and Tf
 
Purification of recombinant B-fragments, labeling with 5-([4,6-dichlorotri-
azin-2-yl]amino)fluorescein and radiolabeling with iodine were essentially
done as described (Johannes et al., 1997). Labeling with Cy3 was done ac-
cording to manufacturerÕs instructions (Amersham Life Science, Inc.). Tf
was labeled with 5-([4,6-dichlorotriazin-2-yl]amino)fluorescein essentially
as described for B-fragment (Johannes et al., 1997). In brief, 1 mg of ferro-
Tf (Sigma) in 20 mM Hepes, pH 7.4, 150 mM NaCl, were added to 250 mM
NaHCO
 
3
 
 and a 20-fold molar excess of 5-([4,6-dichlorotriazin-2-yl]
amino)fluorescein (Sigma) and incubated by end-over-end rotation for 30
min at room temperature. 0.2 mM NH
 
4
 
Cl was added, and labeled protein
was purified on gel filtration columns (Amersham Pharmacia Biotech).
 
Immunofluorescence Studies on Fixed Cells
 
For experiments on fixed cells, 0.75 
 
3 
 
10
 
5
 
 HeLa cells on coverslips were
 
1. 
 
Abbreviations used in this paper:
 
 AP-1, adaptor protein type 1; Bafi, ba-
filomycin A; BFA, brefeldin A; BSA-gold, BSA coupled to gold particles;
CI-MPR, cation-independent mannose 6-phosphate receptor; CytoD, cy-
tochalasin D; Dex3, dextran of 3 kD; EE, early endosomes; LE, late endo-
somes; MPR46, mannose 6-phosphate receptor of 46 kD; Noc, nocoda-
zole; RE, recycling endosomes; Tf, transferrin; TfR, transferrin receptor. 
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placed on ice, fluorophore-labeled B-fragment was added at 1 
 
m
 
g/ml in
Hepes-containing culture medium, and then incubated with cells for 30
min. The cells were then washed three times with ice-cold culture medium
and shifted to either 19.5
 
8
 
C for 45Ð60 min in Hepes-containing culture me-
dium or to 37
 
8
 
C in a CO
 
2
 
 incubator, as indicated in the figure legends.
Marker proteins and antibodies were added at concentrations as follows:
10 
 
m
 
g/ml Tf, 1 
 
m
 
g/ml EGF, 1 mg/ml Dex3, polyclonal antiÐCI-MPR at
1:500 dilution, anti-TGN38 (2-F7-1) at 2 
 
m
 
g/ml. Drugs were added at the
concentrations and duration as indicated in the figure legends. After incu-
bation, cells were washed three times with PBS containing 0.5 mM CaCl
 
2
 
and 1 mM MgCl
 
2
 
, fixed with 3% PFA for 10 min, permeabilized with sa-
ponin, stained with the indicated primary and secondary antibodies, and
then mounted, as described previously (Johannes et al., 1997). Slides were
analyzed by confocal microscopy.
 
Confocal Microscopy
 
Confocal laser scanning microscopy was done on a TCS4D confocal mi-
croscope (Leica AG, Heerbrugg, Switzerland) based on a DM microscope
interfaced with an Argon/Krypton laser. Simultaneous double fluores-
cence acquisitions were performed using the 488-nm and the 568-nm laser
lines to excite FITC and Texas red dyes using 63
 
3
 
 or 100
 
3
 
 oil immersion
Neofluar objectives (numerical aperture 
 
5 
 
1.4). The fluorescence was se-
lected with appropriate double fluorescence dichroic mirror and band
pass filters and measured with blue-greenÐsensitive and red sideÐsensitive
one photomultipliers.
 
Confocal Microscopy on Living Cells
 
HeLa cells were plated on 42-mm glass cover slides. Cy3-labeled B-frag-
ment was bound to these cells and then internalized at 19.5
 
8
 
C, as de-
scribed above. The cover slide was rapidly transferred to a POC-chamber
(Bachofer Laboratoriumsgerte, Reutlingen, Germany) on the stage at
the confocal microscope, and culture medium at 37
 
8
 
C was added. Acquisi-
tions during incubation at 37
 
8
 
C were done at frequencies as indicated in
the figure legends. Care was taken to minimize light exposure as it was no-
ticed that high image acquisition frequencies and high laser light intensi-
ties prevented B-fragment transport to the Golgi apparatus and caused
the appearance of the protein in unidentified structures (not shown). Per
time point, four optical slices were taken. Throughout an 80-min experi-
ment, offset in z-direction was minimal. However, sometimes it was neces-
sary to readjust the microscope. For quantification as shown in Fig. 3 
 
B
 
,
the average fluorescent intensity in the Golgi area was divided by the av-
erage fluorescent intensity over the whole cell. To determine the fraction
of Golgi-associated fluorescent material in percent after 80 min at 37
 
8
 
C,
the ratio between total fluorescent contents in the Golgi area over whole
cell total fluorescent contents was calculated. Background correction fac-
tors were determined from cells that did not have internalized B-frag-
ment. All measurements were done using NIH image software (National
Institutes of Health, Bethesda, MD).
 
Recycling Experiment
 
FITC-coupled B-fragment was added to 0.75 
 
3 
 
10
 
5
 
 HeLa cells and inter-
nalized at 19.5
 
8
 
C for 1 h, as described above. The cells were then put on
ice, and in half of the wells anti-FITC antibody was added at 5Ð20 
 
m
 
g/ml.
In pilot experiments on cell surface bound FITC-labeled B-fragment it
was found that these concentrations allowed for 
 
.
 
80% quenching of
FITC fluorescence. When these concentrations of antibody were added to
cells that had not been treated with FITC-coupled B-fragment, no internal
staining could be detected showing that fluid phase internalization at this
concentration was negligible (not shown). However, if cells had internal-
ized FITC-coupled B-fragment, then also some anti-FITC antibody was
transported inside the cells, presumably in interaction with FITC (not
shown). After 30 min on ice in the presence of anti-FITC antibody, the
cells were either fixed directly or shifted to 37
 
8
 
C for the indicated periods
of time in the continued presence or absence of the anti-FITC antibody
before fixation. The fluorescence per given cell number (30 cells per field)
of mounted cells was then analyzed with an enhanced video camera
(Princeton Instruments, Trenton, NJ). Exposure time was 1.5 s, and the
average fluorescence intensity was determined (five fields per experi-
ment). In the absence of anti-FITC antibody, the average fluorescence
slightly decreased during incubation at 37
 
8
 
C, presumably resulting from a
loss of some cell-associated, FITC-coupled B-fragment, an observation
that is also made if cells that had bound radiolabeled B-fragment are
shifted to 37
 
8
 
C (not shown). To determine quenching due to recycling, av-
erage fluorescence intensity at every time point after incubation at 37
 
8
 
C in
the presence of anti-FITC antibody was corrected for loss of material (see
above) and then divided by the average fluorescence intensity obtained
after the 19.5
 
8
 
C incubation.
 
Immunoelectron Microscopy
 
For immunoelectron microscopy, B-fragment binding (1 
 
m
 
M) was per-
formed on HeLa cells grown on 50-cm
 
2
 
 round tissue culture plates (10
 
7
 
cells), as described above. After washing, cells were incubated at 19.5
 
8
 
C in
Hepes-containing culture medium supplemented in some experiments
with BSA-gold (OD 
 
5 
 
5; a gift from H.J. Geuze, University of Utrecht,
Utrecht, The Netherlands) or Tf-HRP (Pierce Chemical Co.) (20 
 
m
 
g/ml),
fixed directly or shifted to 37
 
8
 
C, as indicated in the figure legends. Fixa-
tion was done by adding to the medium an equivalent volume of 8% PFA
in 0.2 M sodium phosphate buffer, pH 7.4, for 1 h, and further fixation was
done with a fresh 4% PFA solution in 0.1 sodium phosphate buffer for 1 h
more. Cryosectioning and immunogold labeling was done as described
previously (Slot et al., 1991). In the case of mAbs, a rabbit antiÐmouse
linker antibody was used (DAKOPATTS AB, Älvsj, Sweden). For triple
labeling, cryosections were fixed with 1% glutaraldehyde between the first
and second mAb.
 
Quantification on Cryosections
 
Evolution of colocalization between B-fragment and BSA-gold (see Fig. 5
 
D
 
): membrane profiles that were labeled for BSA-gold (at least two gold
particles) were identified by scanning over cryosections of cells that had
internalized B-fragment and BSA-gold at 19.5
 
8
 
C, or that were shifted to
37
 
8
 
C for an additional 15 min. It was then determined whether these pro-
files were also labeled for B-fragment (100 membrane profiles were ana-
lyzed per condition).
To determine whether BSA-goldÐpositive bulk fluid phase elements
(defined as 150Ð300-nm structures that contained 
 
$
 
50 BSA-gold parti-
cles) were also positive for 
 
g
 
-adaptin, the former were identified on fields
of observation that were labeled with 
 
$
 
15 
 
g
 
-adaptinÐspecific gold parti-
cles. 10 such fields with 15 bulk fluid phase elements were analyzed.
Determination of the fraction of marker proteinÐspecific label in
 
g
 
-adaptinÐpositive membrane profiles (Table I): all intracellular B-fragment
(3,809 gold particles), Tf-HRP (2,170 gold particles), or BSA-goldÐspecific
(8,245 gold particles) label on 298 fields of observation was analyzed for
colocalization with 
 
g
 
-adaptin. Colocalization was scored as positive only if
there were at least two 
 
g
 
-adaptinÐspecific gold particles on a membrane
profile on which B-fragment, Tf-HRP, or BSA-goldÐspecific gold particles
were localized in 
 
,
 
100 nm. Depending on the marker protein, determina-
tions were done on one to five independent labeling experiments.
To determine the distribution of B-fragment and Tf-HRPÐspecific im-
munogold label in 
 
g
 
-adaptinÐpositive membrane profiles (see Fig. 10 
 
A
 
),
204 fields of observation (a total number of 2,512 and 1,990 B-fragment
and Tf-HRPÐspecific gold particles, respectively, were counted) with 278
 
g
 
-adaptinÐpositive membrane profiles (at least two 
 
g
 
-adaptinÐspecific
gold labels) that contained 273 and 294 B-fragment and Tf-HRPÐspecific
gold particles, respectively, were analyzed on triple-labeled cryosections
(as shown for example in Fig. 9, 
 
FÐI
 
). For statistical evaluation, B-fragment
or Tf-HRPÐspecific gold particles in 
 
g
 
-adaptinÐpositive membrane pro-
files were taken as denominators. The chi-square test showed a significa-
tive difference (
 
P
 
 , 
 
0.001) between the fraction of B-fragmentÐspecific
gold particles in only B-fragment and 
 
g
 
-adaptinÐpositive membrane pro-
 
Table I. Localization of Marker Proteins in 
 
g
 
-AdaptinÐpositive 
Membrane Profiles
 
Staining of 
 
g
 
-adaptin versus Colocalization
 
%
 
B-fragment 9.7 (
 
6
 
 0.62; 
 
n
 
 
 
5
 
 5)
Tf-HRP 13.2 (
 
6
 
 3.1; 
 
n
 
 
 
5
 
 4)
BSA-gold 0.27 (
 
n
 
 
 
5
 
 1)
 
Quantification was done as described in Materials and Methods on cryosections of
HeLa cells that had internalized BSA-gold and B-fragment or Tf-HRP and B-frag-
ment for 1 h at 19.5¡C. The percentage of marker proteinÐspecific gold label in
 
g
 
-adaptinÐpositive membrane profiles is given (
 
6
 
 SE; 
 
n
 
, the number of independent
determinations on different labeling experiments). 
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files (180 out of 273), when compared with the fraction of Tf-HRPÐspe-
cific gold particles in only Tf-HRP and 
 
g
 
-adaptinÐpositive membrane pro-
files (122 out of 294).
To determine the fraction of 
 
g
 
-adaptinÐpositive membrane profiles co-
labeled with B-fragment and/or Tf-HRP gold particles (see Fig. 10 
 
B
 
), 417
such profiles (at least two 
 
g
 
-adaptinÐspecific gold labels) were analyzed
on three independent triple-labeling experiments (as shown for example
in Fig. 9, 
 
FÐI
 
). Using the chi-squared test for paired series, profiles that
were only labeled for B-fragment were found to be significantly more
abundant than those labeled for only Tf-HRP (
 
P
 
 , 
 
0.01).
 
Retrograde Transport Assay and EGF Degradation
 
Iodinated B-Glyc-KDEL (5,000 cpm/ng) was bound to 10
 
5
 
 HeLa cells as
described above. After incubation at 19.5
 
8
 
C for 1 h and shift to 37
 
8
 
C for
the indicated periods of time, cells were washed three times with PBS and
lysed in SDS sample buffer. Samples were run on 10Ð20% polyacryl-
amideÐSDS gradient gels, analyzed by autoradiography, and quantified
with a PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) using
the ImageQuant software. In each experiment, the percentage of glycosy-
lated protein was determined.
For EGF degradation experiments, HeLa cells were incubated for 30
min in serum-free culture medium. Iodinated EGF (750 Ci/mmol; Amer-
sham Life Science, Inc.) was then added in serum-free Hepes containing
culture medium at 19.5
 
8
 
C for 1 h. Cells were washed, shifted to 37
 
8
 
C for
the indicated periods, and then put on ice. Culture medium was taken off,
the remaining cell-associated radioactivity and the amount of TCA-solu-
ble material in the culture medium were determined. TCA-soluble counts
were then expressed as percentage of total cell-associated radioactivity.
 
Sulfation Analysis
 
Analysis of sulfation on B-(Sulf)
 
2
 
 was essentially done as described (Jo-
hannes et al., 1997). In brief, B-(Sulf)
 
2
 
 was bound to sulfate-starved HeLa
cells (10
 
5
 
) on ice. After washing, the cells were incubated in sulfate-free,
HBSS buffer (GIBCO BRL) at 19.5
 
8
 
C for 1 h, shifted to 37
 
8
 
C for the indi-
cated times (0Ð90 min), and incubated for a final 15 min at 37
 
8
 
C in HBSS
buffer containing 2.5 mCi/ml of [
 
35
 
S]sulfate (1,000 Ci/mmol; Amersham
Life Science, Inc.). B-(Sulf)
 
2
 
 was immunoprecipitated from cell lysates ob-
tained with RIPA buffer using the mAb 13C4 and protein AÐSepharose
(Amersham Pharmacia Biotech). Washed immunoprecipitates were
boiled in sample buffer and analyzed by PhosphorImager after separation
by SDS-PAGE on Tris-Tricine gels (Schgger and von Jagow, 1987).
 
Results
 
Incubation at 19.5
 
8
 
C Induces B-fragment 
Accumulation in EE in HeLa Cells
 
We have previously shown that in HeLa cells, Shiga toxin
B-fragment is transported from the plasma membrane via
endosomes, the TGN and the Golgi apparatus to the ER
(Johannes et al., 1997). To analyze transport from endo-
somes to the Golgi apparatus in further detail, we devel-
oped a low temperature incubation protocol that allowed
the synchronization of this transport step. B-fragment was
incubated with HeLa cells at various temperatures, and it
was found that at 19.58C, the protein accumulated effi-
ciently in endosomes, while its transport to the Golgi ap-
paratus was blocked (Fig. 1). These data are consistent
with earlier studies that showed that the plant toxin ricin is
not transferred to the Golgi apparatus during low temper-
ature incubations, and that under these experimental con-
ditions Shiga toxin is much less toxic to HeLa cells than at
physiological temperatures (Sandvig et al., 1989).
We then compared B-fragment transport through the
endocytic membrane system at 19.58C to that of marker
proteins with established pathways. When fluorophore-
labeled B-fragment (Cy3-coupled, red) and ferro-Tf (flu-
orsceine-coupled, green), a marker protein of EE and RE,
were incubated together with HeLa cells for 1 h at 19.58C,
both were found at the same intracellular sites (Fig. 1 A).
As shown in the inserts of Fig. 1 A, the colocalization be-
tween both proteins was essentially complete. In some
cells, B-fragment and Tf were found to label perinuclear
structures in addition to the peripheral vesicular compart-
ments (Fig. 1 A, arrows). These may represent perinuclear
RE, an hypothesis that is consistent with the observation
that when cells were shifted to 378C, peripheral Tf-label
was more rapidly lost than perinuclear Tf-label (not
shown).
In addition to recycling receptors such as the transferrin
receptor (TfR) back to the plasma membrane, EE also
play an important role in providing access to LE and lyso-
somes. When B-fragment (green fluorescence) and lyso-
some-bound EGF (red fluorescence) were internalized at
19.58C for 1 h, both gave staining patterns that were juxta-
posed to each other, but which did not overlap (Fig. 1 B,
insets, arrows), a distribution that was in marked contrast
to the high degree of colocalization of B-fragment and Tf
(see Fig. 1 A). As shown in Fig. 1 C, juxtaposition of
B-fragmentÐ (green fluorescence) and EGF-labeled (red
fluorescence) structures was essentially lost when cells
that had internalized B-fragment and EGF at 19.58C were
shifted for 10 min to 378C. Under these conditions, EGF
was transported to lysosomes and B-fragment to the Golgi
apparatus (see also below). Since EGF and B-fragment
colocalized at very early time points after internalization
(not shown), these findings suggest that both proteins
were partitioned away from each other at the level of sort-
ing endosomes. Similar results, i.e., a separation between
two marker proteins, were obtained when EGF (red fluo-
rescence) was internalized together with Tf (green fluores-
cence) at 19.58C (Fig. 1 D).
We next compared by confocal microscopy B-fragment
(red fluorescence) transport to that of a fluid phase
marker, FITC-coupled 3-kD dextran (Dex3, green fluo-
rescence) (Fig. 1 E). After cointernalization of Dex3 and
B-fragment at 19.58C, Dex3-positive structures often had a
comet-like appearance in that they were composed of
strongly labeled bulk fluid phase elements (Fig. 1 E, insets,
large arrows) with tail-like extensions (small arrows). Im-
portantly, B-fragment containing structures were found in
the same areas of the cell, but overlapped with the tail-like
elements (Fig. 1 E, insets, small arrows). The situation was
different for cells that had cointernalized Dex3 and EGF
at 19.58C, in the case of which EGF staining overlapped
preferentially with the bulk-phase element of Dex3-con-
taining structures (not shown).
These data suggest that the B-fragment accumulated at
19.58C in EE/RE where the protein segregated from lyso-
some-bound, membrane-associated EGF and from the bulk
of the fluid phase. The observation of B-fragment segrega-
tion from the bulk fluid phase was further confirmed by
electron microscopical studies (see Fig. 5, A and B).
The B-fragment Passes within Minutes from
Early/Recycling Endosomes into the Golgi Apparatus 
with a Fraction of Internalized Molecules Being 
Recycled to the Plasma Membrane
We next set out to follow B-fragment transport from EE/Mallard et al. Direct B-fragment Early Endosome to Golgi Transport 977
RE to the Golgi apparatus. HeLa cells were incubated at
19.58C with B-fragment, transferred for increasing times to
378C, fixed, and then processed for ultracryomicrotomy
followed by labeling with specific antibodies (Fig. 2). As
described above, B-fragment (Fig. 2 A; 10-nm gold parti-
cles) accumulated at 19.58C in vesicular and tubular struc-
tures (50Ð100 nm) that also contained the TfR (15-nm gold
particles). The kinetics of B-fragment transport from EE/
RE to the Golgi apparatus was followed by warming the
cells to 378C. To identify membranes of the TGN, cryosec-
tions were also stained for MPR46, which at steady state in
HeLa cells is mostly localized to the TGN, in contrast to
the CI-MPR (not shown; see below). After 2-min incuba-
tion at 378C (Fig. 2 B), some of the B-fragment (10-nm
gold particles) accumulated already in membranes of the
TGN in colocalization with MPR46 (15-nm gold particles)
(Fig. 2 B), suggesting that the B-fragment entered the
Golgi apparatus at the level of the TGN, in agreement
with our previous results on sulfation siteÐcarrying B-frag-
ment mutants (Johannes et al., 1997). At 10 min (Fig. 2 C),
B-fragment labeling (10-nm gold particles) at the Golgi
apparatus increased significantly. As shown in Fig. 2 D,
double-labeling experiments with B-fragment (15-nm gold
particles) and MPR46 (10-nm gold particles) again identi-
Figure 1. Study of B-frag-
ment colocalization with es-
tablished markers of the en-
docytic pathway during
incubation at 19.58C. The fol-
lowing proteins were incu-
bated with HeLa cells at
19.58C for 1 h: (A) Tf (green)
and B-fragment (red), a large
arrow indicates a region of
perinuclear staining; (B)
EGF (red) and B-fragment
(green), arrows point out re-
gions where B-fragment and
EGF staining are juxtaposed;
(D) TF (green) and EGF
(red); (E) Dex3 (green) and
B-fragment (red), note vesic-
ular (large arrows) and tail-
like (small arrows) Dex3
staining. For marker concen-
trations see Materials and
Methods. Digital images
(four integration frames)
were acquired by confocal
microscopy. The right panel
represents the superposition
of the red and green images.
Insets show selected areas at
higher magnification. In C,
EGF (red) and B-fragment
(green) were internalized at
19.58C, as in B. The cells
were then shifted to 378C for
10 min before fixation. Note
that B-fragment and EGF-
specific labeling did basically
not overlap.The Journal of Cell Biology, Volume 143, 1998 978
fied some of the B-fragmentÐpositive membranes as the
TGN. After 30 min at 378C (Fig. 2 E), all cisternae of the
Golgi apparatus were strongly labeled with B-fragment
(10-nm gold particles).
The fast appearance of B-fragment in the TGN and the
cisternae of the Golgi apparatus was surprising since it
seemed difficult to reconcile such a kinetics with transport
via LE (Mukherjee et al., 1997; see below). The kinetics of
B-fragment transport from EE/RE to the Golgi apparatus
was therefore quantitatively studied following two inde-
pendent protocols, first on living HeLa cells by confocal
microscopy, and second by biochemical means using pro-
tein sulfation as a TGN-specific marker.
For the experiments on living cells, Cy3-labeled B-frag-
ment was internalized into HeLa cells at 19.58C, as de-
scribed above. The cells were transferred to the stage of a
confocal microscope and analyzed at 10Ð15-min intervals
during incubation at 378C. Data obtained in a typical ex-
periment are shown in Fig. 3 A. At time point 4 min at
378C (time necessary to adjust the microscope settings),
B-fragment was found in vesicular cytoplasmic structures
(Fig. 3 A) that corresponded to EE/RE since they were
also labeled by cointernalized fluorescein-tagged Tf (Fig. 3
C). During further incubation at 378C, accumulation in a
juxtanuclear region became visible (Fig. 3 A), which at the
end of the experiment was shown to be staining of the
Golgi apparatus, as judged from colabeling with Golgi
markers on fixed cells (not shown). It was also found that,
using a double-fluorescence detection protocol on living
cells, Cy3-tagged B-fragment accumulated in compart-
Figure 2. Kinetics of B-fragment transport from
EE/RE to the Golgi apparatus revealed by im-
munoelectron microscopy in HeLa cells. (A)
B-fragment was internalized for 1 h at 19.58C,
cells were fixed and prepared for cryosectionning
as described under Materials and Methods.
B-fragment (10-nm gold particles) was detected
in tubular and vesicular elements that were also
labeled for the TfR (15-nm gold particles). Cells
that had internalized B-fragment at 19.58C were
then shifted for 2 min (B), 10 min (CÐD), and 30
min (E) to 378C. Cryosections were stained for
B-fragment (10-nm gold particles in B, C, and E;
15-nm gold particles in D) and MPR46 (15-nm
gold particles in B; 10-nm gold particles in D).
Cryosections that were doubled stained for
MPR46 (in B and D) showed that the B-fragment
entered the Golgi apparatus via the TGN. Bars,
100 nm.Mallard et al. Direct B-fragment Early Endosome to Golgi Transport 979
ments that contained the green fluorescent proteinÐtagged
Golgi marker Rab6 (not shown). Quantification of experi-
ments as those of Fig. 3 A showed that the B-fragment
moved with a t1/2 of 19 min from EE/RE to the Golgi appa-
ratus (Fig. 3 B). The plateau value of the Golgi over cell-
ratio of 3.97 in Fig. 3 B corresponded to 32.1% (6 2.6%; n 5
8) of total cell-associated B-fragmentÐspecific labeling
being concentrated in the Golgi area. It should be pointed
out that at later time points, this value likely reflected a
steady-state concentration of B-fragment in the Golgi ap-
paratus as we have previously shown that in the absence of
an ectopic ER retrieval signal, B-fragment distributed be-
tween the Golgi apparatus and the ER (Johannes et al.,
1997).
Protein sulfation is a TGN-specific posttranslational
modification that is catalyzed by sulfotransferase. We have
previously shown that B-fragment with a COOH-terminal
sulfation site and a KDEL signal can be sulfated (Jo-
hannes et al., 1997). Here we constructed a new mutant
without retrieval signal and with a tandem of sulfation
sites to increase sensitivity. This mutant, termed B-(Sulf)2,
was internalized into HeLa cells for 1 h at 19.58C, and the
cells were then shifted to 378C, as indicated in Fig. 3 C. At
the end of the incubation periods, radioactive sulfate was
added for 15 min to the cells to sample the amount of
B-(Sulf)2 that was in the TGN at this time point. The peak
value for sulfation on B-(Sulf)2 was obtained between 15
and 30 min (Fig. 3 C). During the 60Ð75-min interval, the
Figure 3. Kinetics of B-fragment transport from EE/RE to the Golgi apparatus. (A) Confocal microscopy on living HeLa cells. Fluoro-
phore-labeled B-fragment was internalized for 1 h into HeLa cells at 19.58C, upon which the cells were transferred to the stage of a con-
focal microscope and incubated at 378C. Digital images (four integration frames) were acquired at the indicated time points. Note that
after 4 min, B-fragment was detected in peripheral structures, and then later concentrated in the perinuclear region. (B) Images as
shown in A were quantified, and the fraction of average Golgi associated fluorescence over average total cell-associated fluorescence is
represented in function of incubation time at 378C. The means (6 SE) of eight experiments are shown. The curve was fitted to f(x) 5
1 1 2.97[1 2 exp(20.0363)], r 5 0.9979. (C) Sulfation analysis. B-(Sulf)2 was internalized into HeLa cells at 19.58C, and the cells were
then shifted to 378C. After 0, 15, 30, 60, and 90 min, radioactive sulfate was added for 15 min. Note that B-(Sulf)2 is at its peak concentra-
tion in the TGN during the 15Ð30 min interval. A representative of 2 experiments is shown. In each experiment, the data points were ob-
tained in duplicate. (D) Cotransport of B-fragment and Tf in living cells. For the points 3 and 10 min at 378C, fluorophore-coupled
B-fragment and fluorophore-coupled Tf were internalized as described in A. For the point 30 min at 378C, B-fragment alone was inter-
nalized continuously at 378C, cells were then fixed and stained for the TfR. Note that the B-fragment concentrated in the Golgi area
(large arrow at 10 min), while remaining cytoplasmic B-fragmentÐcontaining structures always were Tf (4 and 10 min) or TfR (30 min)
positive (small arrows at 30 min). Single optical slices were obtained by confocal microscopy.The Journal of Cell Biology, Volume 143, 1998 980
amount of sulfated B-(Sulf)2 decreased to 25% of the peak
value, and then remained stable when sampled after 90Ð
105 min (Fig. 3 C) or after 4 h (not shown). Likely, this
residual material accessible to sulfation represents the
steady state amount of B-(Sulf)2 in the TGN. In summary,
the kinetics obtained by morphological and biochemical
means were comparable, and both experiments confirmed
the hypothesis of rapid B-fragment transport from EE/RE
to the Golgi apparatus.
The possibility to follow transport of fluorophor-labeled
proteins on living cells by confocal microscopy then al-
lowed to compare the exit of B-fragment and Tf from EE/
RE. As shown in Fig. 3 D (left), 3 min after transfer to
378C both proteins still largely colocalized to dispersed cy-
toplasmic structures. After 10 min at 378C (Fig. 3 D, mid-
dle), B-fragment began to accumulate in the Golgi appara-
tus (large arrow; note that the plane of focus is not on the
Golgi apparatus), while Tf staining had visibly diminished
(the Tf image at 10 min was overexposed to compensate
for loss resulting from recycling). However, it should be
noted that the vesicular structures that remained B-frag-
ment labeled also still contained Tf. After longer in-
cubations at 378C, Tf was recycled to the medium and the
B-fragment regrouped in the Golgi apparatus (not shown).
To label B-fragmentÐcontaining intermediate structures
after longer periods of time, HeLa cells were incubated
continuously for 30 min in the presence of Cy3-tagged
B-fragment at 378C, fixed, and then labeled for TfR (Fig. 3
D, right). In agreement with the data in vivo it was found
that all B-fragmentÐlabeled structures outside the Golgi
apparatus were also positive for the TfR (Fig. 3 D, small
arrows).
The presence of B-fragment in EE/RE in colocalization
with Tf prompted us to test whether internalized B-frag-
ment could be recycled to the plasma membrane, as de-
scribed for other toxins (Sandvig and Olsnes, 1979;
Nambiar and Wu, 1995; Alami et al., 1998). FITC-tagged
B-fragment was internalized into HeLa cells at 19.58C for
45 min. The cells were then put on ice and B-fragment that
was still exposed at the cell surface was reacted with an
anti-FITC antibody that quenched FITC fluorescence
upon interaction with the fluorophore. The cells were sub-
sequently transferred to 378C in the continued presence of
the anti-FITC antibody in the extracellular medium. It was
found that 25% of FITC fluorescence that was emitted by
intracellular B-fragments was quenched during a 30-min
incubation at 378C (Fig. 4). This value did not increase any
more upon 50 additional min at 378C in the presence of the
anti-FITC antibody. 25% or 80% of total quenching was
already obtained after 5 or 15 min at 378C, respectively, in-
dicating that B-fragment recycling to the plasma mem-
brane was rapid. It can be concluded that only z25% of
internalized B-fragment was recycled to the plasma mem-
brane during an incubation period (80 min; Fig. 4) suffi-
ciently long to have B-fragment at its peak concentration
in the Golgi apparatus (Fig. 3). It should be added that fol-
lowing B-fragment internalization at 19.58C and subse-
quent incubation at 378C for 5Ð30 min, surface biotinyla-
tion studies failed to detect a significant increase in plasma
membraneÐassociated B-fragment, consistent with the hy-
pothesis of little B-fragment being recycled to the plasma
membrane (not shown). The observation of limited recy-
cling of B-fragment is also consistent with earlier studies
that showed that plasma membrane associated Shiga toxin
became rapidly insensitive to the neutralizing activity of
anti-toxin antibody (Sandvig et al., 1989).
B-fragment thus passed with a half time of 19 min from
EE/RE to the Golgi apparatus with part of the molecules
being recycled to the plasma membrane. The absence of
B-fragmentÐpositive structures outside the Golgi appara-
tus that would have been devoid of Tf or TfR suggested
that the B-fragment did not accumulate outside EE/RE on
its transport to the Golgi apparatus.
Upon Transport to the Golgi Apparatus,
B-fragment Does Not Accumulate in Organelles of
the Late Endocytic Pathway
To directly test whether B-fragment had access to com-
partments of the late endocytic pathway while moving
from EE/RE to the Golgi apparatus, HeLa cells were incu-
bated for 1 h with BSA coupled to gold particles (BSA-
gold) and B-fragment at 19.58C, and then fixed either di-
rectly (Fig. 5, A and B) or shifted for 15 min to 378C before
fixation (Fig. 5 C). The cells were then prepared for cryo-
ultramicrotomy and cryosections were labeled with the in-
dicated antibodies. Upon incubation at 19.58C (Fig. 5, A
and B), BSA-gold (5-nm gold particles) was found filling
tubular and vesicular elements that also contained B-frag-
ment (10-nm gold particles). In addition, strong BSA-gold
accumulation was observed in large compartments (150Ð
300 nm) that were devoid of B-fragment (Fig. 5 B, arrow).
At 19.58C, B-fragment thus seemed to partition away from
the bulk fluid phase, as described above (Fig. 1 E). We
also noted that during low temperature incubation, no
BSA-gold advanced to multivesicular or multilamellar late
endosomes (not shown), demonstrating that transport to
the late endocytic pathway was inhibited at 19.58C (see
also below).
To have quantitative data on the evolution of B-frag-
ment staining with respect to that of lysosome-bound
BSA-gold, we compared the percentage of B-fragmentÐ
positive, BSA-goldÐcontaining structures after the 19.58C
incubation to the percentage of such structures observed
after the additional 15 min shift to 378C (Fig. 5 D). At
19.58C, 76.9% of BSA-goldÐpositive endosomes also con-
tained B-fragment, whereas after 15 min at 378C (for ex-
ample Fig. 5 C), only 16.7% of such double-labeled struc-
dicated periods. Fluorescence at each time point was determined
as described in Materials and Methods and compared with the 0
time point to determine quenching due to newly recycled B-frag-
ment. The means (6 SE) for three independent experiments are
shown.
Figure 4. A fraction of inter-
nalized B-fragment is recy-
cled to the plasma membrane.
FITC-labeled B-fragment
was internalized into HeLa
cells at 19.58C, the cells were
then incubated with anti-
FITC antibody on ice for 30
min and shifted to 378C in the
continued presence of the
anti-FITC antibody for the in-Mallard et al. Direct B-fragment Early Endosome to Golgi Transport 981
Figure 5. B-fragment is detected in compartments of the late endocytic pathway during transport to the Golgi apparatus. (A and B)
HeLa cells were incubated with B-fragment and BSA-gold (5-nm gold particles) at 19.58C. Cryosections were stained with antiÐB-frag-
ment antibody (10-nm gold particles). The arrow in B indicates a region of high BSA-gold concentration (bulk fluid phase) that is de-
void of B-fragment. (C) Cells treated as in A and B were then shifted for 15 min to 378C, fixed, and then cryosections were stained with
antiÐB-fragment antibody (15-nm gold particles) and antiÐCI-MPR antibody (10-nm gold particles). Various endocytic structures are in-
dicated by numbers: areas 1, BSA-goldÐlabeled EE; areas 2, CI-MPR- and BSA-goldÐpositive multivesicular LE; areas 3, CI-MPRÐpos-
itive multilamellar LE. GA, Golgi apparatus. (D) Quantification of BSA-goldÐpositive structures containing or not B-fragment, after
the 19.58C incubation (lanes 1 and 2) or after an additional shift to 378C for 15 min (lanes 3 and 4). (Lanes 1 and 3) Percentage of BSA-
goldÐcontaining structures that also contain B-fragment; (lanes 2 and 4), BSA-goldÐcontaining structures without B-fragment. Bars, 100 nm.
tures could be detected, showing that the high degree of
colocalization between both markers was lost when the
19.58C block was released (for quantification, see Materi-
als and Methods). In Fig. 5 C we also show that the B-frag-
ment (15-nm gold particles) had left EE after the 15-min
incubation at 378C, while these were still stained with
BSA-gold (areas 1). The B-fragment had entered the
Golgi apparatus (Fig. 5 C,  GA,  arrows), as describedThe Journal of Cell Biology, Volume 143, 1998 982
above. Importantly, the toxin subunit was neither detected
in multivesicular LE that were already loaded with BSA-
gold (5-nm gold particles) (areas 2), nor was it found mul-
tilamellar (mature) LE (areas 3). These structures were
labeled with antibodies to the CI-MPR (10-nm gold parti-
cles), which, in contrast to MPR46, is mostly localized in
LE in HeLa cells (not shown; see above).
Even after staining cryosections for only B-fragment in
the absence of BSA-gold (experiments described in Fig.
2), structures with a characteristic morphology of multive-
sicular and multilamellar late endosomes were frequently
observed. However, neither after the 19.58C block nor
during subsequent incubations (2, 10, 30 min) at 378C, any
B-fragment was detected in these structures (not shown).
These direct observations and the quantification described
above thus suggest that the B-fragment did not accumu-
late in compartments of the late endocytic pathway upon
its transfer from EE/RE to the Golgi apparatus.
Figure 6. Drug effects on
B-fragment transport to the
Golgi apparatus. HeLa cells
were incubated with fluo-
rophore-labeled B-fragment
for 1 h at 19.58C, before being
shifted to 378C (A) in the
absence (CTL) or presence
of 1 mM Bafi or 1 mM CytoD,
or (B) in the presence of 5 mg/
ml BFA. The cells were
then  fixed and labeled with
CTR433 antibody (A) or anti-
TfR antibody (B). (C) BFA
inhibits B-fragment transport
to dispersed Golgi cisternae
in Noc-treated HeLa cells.
HeLa cells were pretreated
for 1 h with 10 mM Noc. The
cells were then transferred on
ice and incubated with fluo-
rophore-labeled B-fragment
for 30 min, washed, and then
shifted for 30 min to 378C in
the absence (top row) or pres-
ence (bottom row) of 5 mg/ml
BFA and in the continued
presence of Noc. The cells
were then fixed and stained
for the Golgi marker
CTR433. Note that in the ab-
sence of BFA, B-fragment as-
sociated with the dispersed
cisternae of the Golgi appara-
tus (top), while in the pres-
ence of the drug, the
CTR433-positive cisternae
were devoid of B-fragment
(bottom). Four optical slices
were obtained by confocal
microscopy.Mallard et al. Direct B-fragment Early Endosome to Golgi Transport 983
Drug Effects on B-fragment Transport
To test the influence of drugs with established effects on
the endocytic pathway on B-fragment transport to the
Golgi apparatus, cells that had internalized Cy3-labeled
B-fragment at 19.58C were incubated for 1 h at 378C in
presence of the vacuolar proton pump inhibitor bafilomy-
cin A1 (Bafi), the actin-depolymerizing drug cytochalasin
D (CytoD), or the fungal metabolite brefeldin A (BFA)
(Fig. 6). Neither CytoD nor Bafi prevented B-fragment
appearance in the Golgi apparatus, stained with the me-
dial Golgi marker CTR433 (Fig. 6 A), consistent with re-
cently published observations (Schapiro et al., 1998). The
same results were obtained when the cells were pretreated
for up to 2 h with these drugs (not shown). In the presence
of BFA, which in addition to its profound effects on the
biosynthetic/secretory pathway (for review see Klausner
et al., 1992) has somewhat more subtle effects on the en-
docytic membrane system (Hunziker et al., 1991; Lippin-
cott-Schwartz et al., 1991; Wood et al., 1991; Strous et al.,
1993; for review see Hunziker et al., 1992), B-fragment ac-
cumulated in tubular elements that also contained the TfR
(Fig. 6 B). The protein remained associated with these tu-
bules even when the cells were incubated at 378C for up to
4 h in presence of the drug (not shown). In the presence of
the microtubule-destabilizing agent nocodazole (Noc),
B-fragment was still transported to the dispersed cisternae
of the Golgi apparatus where it colocalized with the Golgi
marker CTR433 (Fig. 6 C, top row; see also Johannes et al.,
1997) and with the TGN marker protein TGN38 (not
shown). Interestingly, when Noc-treated cells were also
exposed to BFA, CTR433-positive (Fig. 6 C, bottom row)
Golgi compartments that persisted under these conditions
(Lippincott-Schwartz et al., 1990) were not labeled by
B-fragment any more, suggesting that transport between
the BFA-induced, B-fragment-, and TfR-positive mem-
brane system and the Golgi remnants had ceased.
To obtain quantitative data on drug effects on B-frag-
ment transport, we used a previously constructed chimeric
B-fragment in which the B-fragment was fused to a N-gly-
cosylation site and the KDEL retrieval signal, yielding a
protein termed B-Glyc-KDEL (Johannes et al., 1997). As
wild-type B-fragment, B-Glyc-KDEL is transported from
the plasma membrane to the ER, where the chimeric pro-
tein gets progressively glycosylated. The determination of
the percentage of glycosylated, cell-associated B-Glyc-
KDEL at any given time point after internalization repre-
sents thus a quantitative measure for the proteinÕs trans-
port to the ER. Fig. 7 A shows the results of glycosylation
analysis on B-Glyc-KDEL, which was incubated with
HeLa cells in the presence of drugs. Control cells (Fig. 7 A,
closed circles) and cells that had been pretreated for 2 h
with Bafi (open squares) or CytoD (open diamonds) and
that had bound iodinated B-Glyc-KDEL on ice were
shifted to 378C in the continued presence of the drugs.
BFA (Fig. 7 A, closed diamonds) was only added upon
temperature shift to 378C. Cell lysates taken after the indi-
cated times at 378C were analyzed by autoradiography.
Bafi and CytoD had no effect on B-Glyc-KDEL glycosyla-
tion (Fig. 7 A). The same results were obtained when cells
were incubated in the presence of the proton pump inhibi-
tor concanamycin B, the weak base ammonium chloride or
when Bafi treatment was combined with chloroquine
treatment, the weak base chloroquine assuring a rapid dis-
sipation of endosomal pH (not shown). In contrast, no gly-
cosylation of B-Glyc-KDEL was detectable in the pres-
ence of BFA (Fig. 7 A,  closed diamonds), even after
incubations of #15 h (not shown).
In parallel, we analyzed the lysosomal degradation of
EGF as a control for the efficiency of the drug treatments
(Fig. 7 B). Iodinated EGF was internalized into HeLa cells
at 19.58C. To test whether the block at 19.58C prevented
access to lysosomes, cells were incubated for #8 h with ra-
diolabled EGF at 19.58C. The number of TCA-soluble
counts remained stable under these conditions (not shown),
indicating that EGF was not transferred to a degradative
(late) compartment of the endocytic pathway. The cells
that had internalized EGF at low temperatures were then
shifted to 378C. In the absence of the drugs (Fig. 7 B,
closed  circles), EGF degradation was complete after 90
min. As expected, Bafi (Fig. 7 B,  open squares) almost
completely inhibited degradation, as judged from the fact
that the amount of extracellular TCA-soluble material de-
rived from EGF remained stable. CytoD induced a delay
Figure 7. Quantification of
drug effects on B-fragment
transport to the biosynthetic/
secretory pathway. (A) HeLa
cells were preincubated 2 h
with 1 mM Bafi (open
squares) and 1 mM CytoD
(open diamonds). The cells
were then transferred on ice
and incubated with 50 nM io-
dinated B-Glyc-KDEL for
30 min. After washing, the
cells were shifted to 378C in
the continued presence of the
drugs. BFA (closed dia-
monds) was added only upon
temperature shift to 378C.
Control cells (closed circles)
were not treated with drugs.
After the indicated times at
378C, cells were lysed in sam-
ple buffer, and then lysates
were analyzed on 10Ð20%
polyacrylamideÐSDS gradi-
ent gels, followed by autora-
diography. The percentage of
glycosylated B-Glyc-KDEL
was expressed in function of
incubation time. The means
of three independent experiments (6 SE) are shown. (B) Radio-
labeled EGF was internalized into HeLa cells at 19.58C. The cells
were then shifted to 378C in the absence (closed circles) or pres-
ence of 1 mM Bafi (open squares), 1 mM CytoD (open circles), or
5 mg/ml BFA (open diamonds). After the indicated times at 378C,
the number of TCA-soluble counts in the culture medium was
determined as described in Materials and Methods. A represen-
tative of two experiments is shown. (C) Iodinated B-Glyc-KDEL
was bound to HeLa cells, as described in A. The cells were then
shifted to 378C, and 5 mg/ml BFA was added after the indicated
times (230 min to 4 h, with respect to the beginning of B-Glyc-
KDEL internalization). After 4 h at 378C, cells were lysed and
glycosylated B-Glyc-KDEL was determined as described in A. A
representative of two experiments is shown.The Journal of Cell Biology, Volume 143, 1998 984
in EGF degradation (Fig. 7 B,  open circles), consistent
with its proposed effect on transport to lysosomes (Durr-
bach et al., 1996). In contrast, despite its morphological ef-
fects (Fig. 6 B), BFA did not affect EGF degradation in ly-
sosomes (Fig. 7 B, open diamonds), consistent with a study
by Stoorvogel et al. (1993) that showed no significant inhi-
bition by BFA of protein transport to lysosomes and lyso-
somal degradation.
B-fragment transport to the Golgi apparatus and to the
ER thus seemed to be independent of the maintenance of
an acidic environment in endosomes and independent of
the actin cytoskeleton. In contrast, BFA induced the accu-
mulation of the B-fragment in a tubular membrane com-
partment that contained the TfR, and inhibited B-Glyc-
KDEL transport to the ER and B-fragment transport to
Golgi remnants in Noc-treated cells.
In this context it should be mentioned that we have pre-
viously reported that in HeLa cells, radiolabeled B-frag-
ment is not transformed into TCA soluble material (Jo-
hannes et al., 1997), suggesting that in these cells the
protein is not transported to lysosomes, an observation
which is consistent with the absence of colocalization with
lysosomal marker proteins (Johannes et al., 1997), and
with the absence of the protein from heavy fractions on
Percoll gradients (not shown). Here we observed that dur-
ing incubations of radiolabeled B-fragment with HeLa
cells for #6 h in the presence of BFA, no TCA-precipita-
ble counts appeared in the medium (not shown). Thus,
even when its exit from the endosomal membrane system
was blocked by BFA (see above), B-fragment did not Òdif-
fuseÓ to degradative (late) compartments of the endocytic
pathway, despite that this transport route was still open for
other proteins, e.g., EGF.
In another experiment, BFA was added at various times
after the initiation of B-Glyc-KDEL internalization from
the plasma membrane by temperature shift to 378C (Fig. 7
C). It was found that when added after 90 min, the drug no
longer had an effect on glycosylation. The t1/2 of inhibition
was 30 min (Fig. 7 C), in good agreement with the above
described kinetics of B-fragment transport from EE/RE to
the Golgi apparatus (see Fig. 3 B; note that in Fig. 7 C,
transport is sampled from the plasma membrane). These
data thus suggest a correlation between B-fragment trans-
port from EE/RE to the Golgi apparatus and the passage
of the BFA-sensitive transport step.
B-fragment Colocalizes with g-Adaptin on Membranes 
of Early/Recycling Endosomes
The BFA-induced inhibition of B-fragment exit from TfR-
positive membrane compartments suggested that ADP ri-
bosylation factorÐsensitive vesicular coats could play a
role in this process (Donaldson et al., 1992; Helms and
Rothman, 1992). We thus set out to study the distribution
of vesicular coat proteins on endosomes. Different vesicu-
lar coats have been localized on endosomes, among the
best studied are coatomer type IÐlike coats and clathrin
coats (Louvard et al., 1983; Takei et al., 1995; Whitney et al.,
1995; Aniento et al., 1996; Stoorvogel et al., 1996; Daro et al.,
1997; Gu et al., 1997). We here made the observation that
during a 1-h incubation at 19.58C, a component of AP-1Ð
type clathrin coats, g-adaptin, was shifted from its localiza-
tion at steady state in the TGN to B-fragment containing
EE/RE (Fig. 8, A and B). If the cells were then incubated
at 378C for 10 min (not shown) or 30 min (Fig. 8, C and D),
g-adaptin reassociated with TGN membranes while the
B-fragment accumulated in the TGN/Golgi apparatus.
Cryosections of cells that had internalized B-fragment
and BSA-gold at 19.58C and that were then shifted for var-
ious times to 378C, were labeled with antiÐg-adaptin and
antiÐB-fragment antibodies. At 19.58C, B-fragment (15-nm
gold particles) and g-adaptin (10-nm gold particles) were
found on the same coated membrane profiles (50Ð80 nm)
(Fig. 9, AÐC, arrowheads). The B-fragment and g-adaptinÐ
labeled structures sometimes were connected with endo-
somal membranes (Fig. 9, B and C), while in other in-
stances seemingly free vesicles could be detected that may
represent membrane buds that were cut perpendicularly
(Fig. 9, AÐC). In some cases, B-fragmentÐpositive profiles
were devoid of g-adaptin, and vice versa (Fig. 9, B and C).
In the same experiments it was noted that strongly BSA-
goldÐpositive structures (bulk fluid phase) were devoid of
g-adaptin staining (not shown), suggesting that g-adaptin
localization on subdomains of EE/RE at 19.58C was a spe-
cific event. Investigations using antibodies to clathrin (10-nm
gold particles) combined with B-fragment (15-nm gold
particles) labeling were also carried out on the experiment
described above (Fig. 9, D and E). Again, membrane pro-
files stained with both antibodies (Fig. 9, D and E, arrows)
were observed.
As described above, B-fragment colocalized extensively
Figure 8. At 19.58C, the g-adaptin subunit of AP-1Ðtype clath-
rin coats is relocalized from the TGN to EE/RE. Fluorophore-
labeled B-fragment (A and C) was internalized for 1 h into HeLa
cells at 19.58C. The cells were then either fixed directly (A and
B), or shifted for 30 min to 378C (C and D) before fixation and
staining for g-adaptin (B and D). Note that at 19.58C, g-adaptin
and B-fragment colocalized on EE/RE (A and B), and after shift
to 378C, g-adaptin was relocalized to the TGN, in parallel with
B-fragment accumulation in Golgi cisternae (C and D).Mallard et al. Direct B-fragment Early Endosome to Golgi Transport 985
with Tf if incubated with HeLa cells at 19.58C (see Fig. 1).
We therefore investigated whether both molecules would
also be found together in g-adaptin/clathrinÐcoated mem-
brane profiles. HeLa cells were incubated with B-fragment
and Tf coupled to HRP (Tf-HRP) at 19.58C for 1 h. Tf-
HRP, which is transported as Tf (see for example Stoorvo-
gel et al., 1996), was chosen since good anti-HRP antibod-
ies exist. Cryosections from these cells were triple-labeled
for B-fragment (15-nm gold particles), Tf-HRP (10-nm
gold particles), and g-adaptin (5-nm gold particles) (Fig. 9,
FÐI). Again, B-fragment was found in colocalization with
g-adaptin, and some of the g-adaptinÐpositive membrane
profiles were also labeled for Tf-HRP, while in other
cases triple-labeled profiles were detected (Fig. 9, FÐI, ar-
rowheads). Quantification of double- and triple-labeled
sections showed that 9.7% of total internalized B-frag-
ment and 13.2% of total internalized Tf-HRP colocalized
with g-adaptin (Table I). Despite their comparable presence
in g-adaptin positive structures, B-fragment and Tf-HRP
were found to have significantly different distributions in
these structures (Fig. 10). Most B-fragment gold particles
that colocalized with g-adaptin were found in structures
that were not labeled for Tf-HRP (66%), while in the case
of Tf-HRP most gold particles that colocalized with g-adap-
tin were found in triple labeled structures (58%) (Fig. 10
A). The same differences were observed when g-adaptinÐ
positive structures were analyzed for the presence or ab-
sence of B-fragment or Tf-HRP (Fig. 10 B). Significantly
more g-adaptinÐpositive structures were labeled for only
B-fragment (30%), when compared with g-adaptinÐposi-
tive structures labeled for Tf-HRP only (17.1%).
In contrast to B-fragment and Tf-HRP, only a small per-
centage of internalized BSA-gold was present in g-adap-
tinÐpositive structures (0.27%) (Table I), consistent with
earlier studies which showed that fluid phase is basically
excluded from transport to the Golgi apparatus (see Sand-
Figure 9. g-Adaptin and clathrin colocalize with B-fragment and Tf-HRP at the ultrastructural level on coated membrane profiles of
EE/RE. (AÐE) HeLa cells were incubated for 1 h with B-fragment and BSA-gold (5-nm gold particles) at 19.58C. Cryosections of these
cells were labeled with antiÐB-fragment antibody (15-nm gold particles) and antiÐg-adaptin antibody (10-nm gold particles in AÐC) or
anti-clathrin antibody (10-nm gold particles in D and E). In AÐC, arrowheads indicate regions of colocalization between g-adaptin and
B-fragment. In D and E, arrowheads point out regions of colocalization between clathrin and B-fragment. (F-I) Serum-starved HeLa
cells were incubated for 1 h with B-fragment and Tf-HRP at 19.58C. Cryosections of these cells were labeled with antiÐB-fragment anti-
body (15-nm gold particles), anti-HRP antibody (10-nm gold particles), and antiÐg-adaptin antibody (5-nm gold particles). Arrowheads
in F and G point to double- or triple-labeled profiles. (H and I) Magnification of selected structures. Bars, 100 nm.The Journal of Cell Biology, Volume 143, 1998 986
vig et al., 1994 and references therein), and that even at
378C only a small fraction of fluid phase is recycled (Goud
et al., 1984).
TGN38 and the B-fragment Colocalize during 
Transport to the Golgi Apparatus
To test whether a cellular protein could follow the same
route as the B-fragment, B-fragment was incubated at
378C with HeLa cells in the presence of antibodies di-
rected either to the CI-MPR or to rat TGN38 (Fig. 11).
The CI-MPR and TGN38 both cycle between endosomes
and the TGN (Humphrey et al., 1993; Reaves et al., 1993;
Chapman and Munro, 1994; Ponnambalam et al., 1994;
Munier-Lehmann et al., 1996). The antibodies were added
at concentrations at which fluid phase internalization was
not detectable (see Materials and Methods). After increas-
ing periods of time, the cells were washed, fixed, and then
processed for immunofluorescence. At 10 min, colabeling
was found for TGN38 and B-fragment in vesicular struc-
tures at the level of EE of rat TGN38-expressing HeLa
cells (Fig. 11 A, top row). After 30 min (not shown) or 60
min at 378C (Fig. 11 A, bottom row), both proteins arrived
in the Golgi apparatus. They labeled overlapping struc-
tures with subtle differences that may have resulted from
B-fragment transport into the cisternae of the Golgi appa-
ratus, while TGN38 remained confined to the TGN. In ac-
cordance with the hypothesis that TGN38 and the B-frag-
ment could both follow the same route from EE/RE to the
Golgi apparatus it was also observed that after BFA treat-
ment, both proteins were found in tubular elements (not
shown).
The internalized antiÐCI-MPR antibody gave a dis-
tinctly different staining pattern than B-fragment. After 30
min (Fig. 11 B, top row) 1 h, 2 h (not shown), or 4 h (Fig.
11 B, bottom row) at 378C, the antibody labeled vesicular
elements that (especially after longer incubation) were
concentrated in the perinuclear region consistent with LE
or Golgi localization. At none of the analyzed time points,
CI-MPR labeling and B-fragmentÐpositive structures over-
lapped to a significant extend. These data thus suggest that
B-fragment may be transported via the same pathway as
TGN38 from EE/RE to the Golgi apparatus, while the
CI-MPR may use a different transport route.
Discussion
In this study, we raised the question as to how Shiga toxin
B-fragment is transported from the endocytic compart-
ment to the Golgi apparatus. Our data suggest that B-frag-
ment passes directly from EE/RE to the Golgi apparatus,
circumventing the late endocytic pathway, and that in this
basically unexplored transport route, B-fragment sorting
at the level of EE/RE implicates AP-1Ðtype clathrin coats.
Shiga Toxin B-fragment Transport from EE/RE to the 
Golgi Apparatus
To characterize the pathway followed by B-fragment be-
tween EE/RE and the Golgi apparatus, we took advantage
of our finding that a temperature block at 19.58C allowed a
synchronization of B-fragment transport at the level of
EE/RE. Using this temperature block protocol and subse-
quent shift to 378C, the following observations were made
that support the hypothesis of the existence of a direct
transport pathway between EE/RE and the Golgi appara-
tus. First, at low temperature incubations, B-fragment was
segregated from markers that were bound for LE and ly-
sosomes, such as EGF, even if cells were incubated for
prolonged periods. If the B-fragment was destined for the
late endocytic pathway, one would have expected an accu-
mulation at the entry site of this pathway, i.e., structures
that were stained by EGF. Second, upon incubation at low
temperatures, the fluid phase marker BSA-gold filled the
membranes of EE, where it colocalized with cointernal-
ized B-fragment. However, upon subsequent shift to 378C,
both markers efficiently separated when the bulk of BSA-
gold was transferred to the late endocytic pathway, while
the B-fragment was transported to the Golgi apparatus.
Third, as judged from light microscopical studies, all cyto-
plasmic B-fragment containing structures also remained
TfR positive, suggesting that on its transport to the Golgi
apparatus, B-fragment did not accumulate outside EE.
Figure 10. Quantification of g-adaptinÐpositive membrane pro-
files. (A) Distribution of B-fragment and Tf-HRPÐspecific gold
particles in g-adaptinÐpositive membrane profiles. The columns
represent the fraction of B-fragment (lanes 1 and 2) in g-adaptinÐ
positive structures that were labeled (lane 2) or not labeled
(lane 1) for Tf-HRP, or the fraction of Tf-HRP (lanes 3 and 4)
in g-adaptinÐpositive structures that were labeled (lane 4) or not
labeled (lane 3) for B-fragment. (B) Characterization of g-adap-
tinÐpositive structures. Note that significantly more g-adaptinÐ
positive profiles were labeled for only B-fragment (left column),
compared with such structures labeled for only Tf-HRP (right
column). * and **, direct comparison shows that these conditions
are significantly different (P , 0.01; see Materials and Methods).Mallard et al. Direct B-fragment Early Endosome to Golgi Transport 987
Electron microscopical observations further supported the
idea of a direct transport route as B-fragment was not de-
tected in multivesicular or multilamellar LE at any time
point. Fourth, we show that after as little as 2 min at 378C
after the temperature block, B-fragment could be detected
in the cisternae of the Golgi apparatus, which became
strongly labeled after 10 min. This rapid kinetics is consis-
tent with a direct passage from EE/RE to the Golgi appa-
ratus. Fifth, the data presented in Fig. 3 B were fitted to an
exponential raise curve with a time constant of 0.036
min21, indicating the existence of a single rate-limiting
step in EE/RE-to-Golgi transport. This observation is
most easily explained if EE/RE derived transport interme-
diates fuse directly with the Golgi apparatus as acceptor
compartment, without passing through other compart-
ments. Sixth, drugs such as CytoD, ConB, Bafi, chloro-
quine, and ammonium chloride, with defined effects on
the late endocytic pathway did not interfere with B-frag-
ment transport to the Golgi apparatus and the ER. Par-
ticularly for the pH neutralizing drugs, an inhibition of
Figure 11. B-fragment and anti-TGN38, but not
antiÐCI-MPR, are found in the same structures.
(A) Fluorophore-labeled B-fragment (left) and
anti-TGN38 antibody (right) were bound to
HeLa C7 cells on ice, upon which the cells were
incubated at 378C for 10 min (top) and 60 min
(bottom) in the continued presence of both pro-
teins. The cells were then fixed and stained for
internalized anti-TGN38 antibody (right). (B)
Fluorophore-labeled B-fragment (left) and antiÐ
CI-MPR antibody (right) were bound to HeLa
cells on ice, upon which the cells were incubated
at 378C for 30 min (top) and 4 h (bottom) in the
continued presence of both proteins. The cells
were then fixed and stained for internalized antiÐ
CI-MPR antibody (right).The Journal of Cell Biology, Volume 143, 1998 988
the formation of LE-bound endosomal carrier vesicles
(Clague et al., 1994; Aniento et al., 1996) and an inhibition
of transport from LE to lysosomes (Benaroch et al., 1995;
van Weert et al., 1995) has been described. Seventh, BFA
was found to induce B-fragment accumulation in TfR-con-
taining membrane tubules and also inhibited B-fragment
transport to the ER. Strikingly, no B-fragment degra-
dation (appearance of TCA-soluble material) became ap-
parent, even after prolonged incubations at 378C in the
presence of BFA, whereas the transport route to LE/lyso-
somes was still open for other proteins (e.g., EGF), thus
strongly suggesting that the B-fragment did not access late
(degradative) compartments of the endocytic pathway. In
addition, if LE were the exit point for B-fragment trans-
port to the Golgi apparatus, one would have expected that
in the presence of BFA, the protein would have accumu-
lated in this compartment.
The existence of a direct transport route between EE/
RE and the TGN was first suggested in studies showing
that small quantities of internalized Tf could be detected in
the TGN (Fishman and Fine, 1987; Stoorvogel et al., 1988).
Our hypothesis that protein toxins such as Shiga toxin may
use this route is consistent with studies by Balch and col-
leagues (Simpson et al., 1995) who showed that another
toxin, the plant toxin ricin, seemed to reach the Golgi appa-
ratus even in cells that expressed a dominant-negative mu-
tant of the small GTP-binding protein Rab9. Rab9 localizes
to late endosomes and to the TGN and regulates transport
of the CI-MPR, presumably from LE to the TGN (Lom-
bardi et al., 1993; Riederer et al., 1994). One would thus
have expected an effect of the dominant-negative mutant
of Rab9 on ricin transport if this transport passed via LE.
The proposed B-fragment pathway from EE/RE to the
Golgi apparatus may be shared by cellular proteins. We
found that TGN38 colocalized with B-fragment during its
transport to the TGN, and both, B-fragment and TGN38
distributions in cells were affected in the same way by
BFA treatment. In addition, the kinetics of B-fragment
and TGN38 transport to the Golgi apparatus were compa-
rable. In agreement with these data, the group of F.R.
Maxfield (Cornell University Medical College, New York)
recently showed that an epitope-tagged version of TGN38
(Humphrey et al., 1993) is transported with a t1/2 of 45 min
from the plasma membrane to the TGN in CHO cells, with
first TGN38-label appearing in the TGN after only 10 min
(see Note Added in Proof). Such kinetics compares well
with the t1/2 of 19 min determined in this study for B-frag-
ment transport from EE/RE to the TGN/Golgi apparatus,
especially when it is considered that 80% of internalized
TGN38 were recycled to the plasma membrane, thus in-
ducing a delay with respect to Golgi transport. In contrast
to TGN38, there was little colocalization between the CI-
MPR and B-fragment in endosomes. These data suggest
that the CI-MPR may follow a different transport route
from endosomes to the Golgi apparatus, e.g., from LE. In
this context it should also be added that the kinetics of
B-fragment and CI-MPR transport to the TGN appears to
be quite different. Whereas the t1/2 for B-fragment is 19
min, resialylation in the TGN of CI-MPR that has been
desialylated at the plasma membrane (thus sampling
plasma membrane to TGN transport) occurs with a t1/2 of
1Ð2 h (Jin et al., 1989).
The suggestion of a common pathway for both, B-frag-
ment and TGN38 is in apparent contradiction with the fact
that B-fragment transport to the Golgi apparatus (and the
ER) is not affected by chemicals that raise endosomal and
Golgi pH, while TGN38 has been reported to be retained
in endosomes under similar conditions (Chapman and
Munro, 1994; Reaves and Banting, 1994a). It is possible
that the transmembrane protein TGN38 relies on a sorting
mechanism for Golgi transport whose activity is sensitive
to luminal pH changes, while the glycolipid binding B-frag-
ment would follow the flow of lipids which may be gov-
erned by different (pH insensitive) mechanisms, such as
sorting into specialized environments in endosomes, as sug-
gested for GPI-anchored proteins (Maxfield and Mayor,
1997). It should also be mentioned that on HeLa cells
transfected with rat TGN38, we did not detect a major ef-
fect of Bafi and combined Bafi and chloroquine treat-
ments on anti-TGN38 transport to the TGN (not shown).
This divergence with the above mentioned studies (Chap-
man and Munro, 1994; Reaves and Banting, 1994a) may be
attributed to cell type differences.
Sorting of B-fragment into Golgi
Transport Intermediates
Another important finding of this study is the observation
that during incubation at 19.58C, B-fragment and EGF
were localized to juxtaposed structures suggesting that
both proteins partitioned into separate compartments or
into subdomains of the same compartment, i.e., sorting en-
dosomes. In fact, it has been proposed that sorting at the
level of sorting endosomes may occur through the forma-
tion of subdomains with high or low membrane-to-volume
ratios (Geuze et al., 1983, 1987), the former being of tubu-
lar morphology and enriched in proteins and lipids des-
tined for the recycling pathway, while the latter are of ve-
sicular morphology and enriched in proteins and lipids
destined for the late endosomal pathway (for review see
Gruenberg and Maxfield, 1995; Mukherjee et al., 1997).
Through such physical separation, enrichment of the re-
spective cargo would be achieved. A prediction from this
model is that a fluid phase marker should be mostly en-
riched in subdomains of sorting endosomes that contain
proteins destined for late endosomes (bulk fluid phase do-
mains). Using Dex3 and BSA-gold as fluid phase markers,
we actually observed that the bulk of these markers segre-
gated from B-fragment, but not from EGF.
In addition to the described partition mechanism, which
may be especially important at the level of endosomes, it
has been demonstrated that protein coats play a general
role in sorting (Rothman and Wieland, 1996; Schekman
and Orci, 1996). Different subunits of clathrin and coat-
omer protein coats have been detected on endosomes by
morphological and biochemical means (Louvard et al., 1983;
Takei et al., 1995; Whitney et al., 1995; Aniento et al., 1996;
Stoorvogel et al., 1996; Daro et al., 1997; Gu et al., 1997).
Here we have found that: (a) As shown for the TGN (Mat-
lin and Simons, 1983; Brown et al., 1995), the temperature
block at 19.58C also prevented exit from EE/RE (B-frag-
ment). (b) In the presence of BFA, B-fragment remained
confined to TfR-containing membrane tubules. BFA is
thought to affect the function of small GTP-binding pro-Mallard et al. Direct B-fragment Early Endosome to Golgi Transport 989
teins of the ADP ribosylation factor family (Donaldson et
al., 1992; Helms and Rothman, 1992), and a role of ADP
ribosylation factors in the formation of AP-1 vesicles has
been suggested (Robinson and Kreis, 1992; Stamnes and
Rothman, 1993; Traub et al., 1993; Le Borgne et al., 1996;
Salamero et al., 1996; Le Borgne and Hoflack, 1997). In
addition, AP-1 has been shown to bind to a Tyr-containing
signal in the cytoplasmic tail of TGN38 (Reaves and
Banting, 1994b; Ohno et al., 1995). (c) During low temper-
ature incubations (19.58C), the g-adaptin subunit of AP-1
was relocalized from the TGN to EE/RE where it colocal-
ized at the light microscopical level with the B-fragment.
(d) Our electron microscopical data show that g-adaptin
colocalized with the B-fragment in clathrin-coated mem-
brane profiles on EE/RE. 47% of all g-adaptinÐpositive
structures were also labeled with B-fragment, and 9.7% of
all internalized B-fragment was found in g-adaptinÐposi-
tive coated membrane profiles. This figure compares well
with data on receptor concentration in coated pits at the
plasma membrane, e.g., the Fc-receptor was found to
localize at 8% in coated pits (Miettinen et al., 1992),
and the TfR at z10% (Hansen et al., 1992, and refer-
ences therein). Importantly, B-fragment accumulation in
g-adaptinÐpositive coated pits was much more pro-
nounced than that of BSA-gold (33-fold), further suggest-
ing that g-adaptinÐpositive structures play a role in B-frag-
ment sorting.
Tf was also found to colocalize with g-adaptin in coated
membrane profiles on endosomes. This observation is con-
sistent with a recent study by Hopkins and colleagues who
described the presence of the TfR in g-adaptinÐcoated pu-
tative basolateral recycling intermediates in polarized cells
(Futter et al., 1998). Since recycling continues at a reduced
rate during low temperature incubations (Iacopetta and
Morgan, 1983; van der Ende et al., 1989), B-fragmentÐ and
Tf-HRPÐcontaining,  g-adaptinÐpositive membrane pro-
files observed at 19.58C could correspond to recycling
intermediates. However, our triple-labeling experiments
further show that aside from g-adaptinÐpositive structures
that contain both, B-fragment and Tf-HRP, g-adaptinÐ
positive structures labeled for only B-fragment are signifi-
cantly more abundant than g-adaptinÐpositive structures
labeled for Tf-HRP only. Altogether, these data directly
implicate g-adaptin in B-fragment sorting at the level of
EE, and they suggest that in addition to a putative role in
recycling, g-adaptin may also participate in transport steps
in which B-fragment rather than Tf is the predominant
cargo molecule, i.e., transport from EE/RE to the Golgi
apparatus. It may finally be noted that the B-fragmentÐ
and g-adaptinÐpositive, but Tf-HRPÐnegative structures
detected in this study by electron microscopy could corre-
spond to the peripheral, g-adaptinÐpositive, but TfR-nega-
tive membranes described by Futter et al. (1998) in immu-
nofluorescence experiments.
Recently, Sandvig and colleagues (Llorente et al., 1998)
demonstrated a role for dynamins in ricin transport from
endosomes to the Golgi apparatus. Dynamins have been
directly implicated through genetic, morphological, and
biochemical evidence in the formation of clathrin-coated
vesicles (for review see De Camilli et al., 1995; Warnock
and Schmid, 1996), and a function for dynamins in trans-
port of toxins from EE/RE to the Golgi apparatus would
thus be consistent with the proposed role of clathrin
coated vesicles in this pathway (this study).
The B-fragment represents an important tool to study
an as yet basically unexplored transport route. Future
studies will help to unravel in further detail the molecular
mechanisms that underlie transport between EE/RE and
the Golgi apparatus.
We thank R. Golsteyn, S. Amigorena, and P. Bnaroch for critical reading
of the manuscript and D. Meur and D. Morineau for help with the photo-
graphic work. 
This study was supported by grants from the European Union (ERB
FMRX CT 96 0020) and Human Frontier Science Program to B. Goud,
and from the Ligue Nationale Contre le Cancer to L. Johannes and C.
Antony.
Received for publication 2 June 1998 and in revised form 18 August 1998.
Note Added in Proof. While this article was in press, the work by F.R.
Maxfield and colleagues on TGN38 transport through the endocytic mem-
brane system has been published (Ghosh, R.N., W.G. Mallet, T.T. Soe,
T.E. McGraw, and F.R. Maxfield). 1998. J. Cell Biol. 142:923Ð936.
References
Alami, M., M.-P. Taupiac, H. Reggio, A. Bienvene, and B. Beaumelle. 1998.
Involvement of ATP-dependent Pseudomonas exotoxin translocation from
a late recycling compartment in lymphocyte intoxication procedure. Mol.
Biol. Cell. 9:387Ð402.
Aniento, F., F. Gu, R.G. Parton, and J. Gruenberg. 1996. An endosomal beta
COP is involved in the pH-dependent formation of transport vesicles des-
tined for late endosomes. J. Cell Biol. 133:29Ð41.
Benaroch, P., M. Yilla, G. Raposo, K. Ito, K. Miwa, H.J. Geuze, and H.L.
Ploegh. 1995. How MHC class II molecules reach the endocytic pathway.
EMBO (Eur. Mol. Biol. Organ.) J. 14:37Ð49.
Brown, W.J., D.B. DeWald, S.D. Emr, H. Plutner, and W.E. Balch. 1995. Role
for phosphatidylinositol 3-kinase in the sorting and transport of newly syn-
thesized lysosomal enzymes in mammalian cells. J. Cell Biol. 130:781Ð796.
Chapman, R.E., and S. Munro. 1994. Retrieval of TGN proteins from the cell
surface requires endosomal acidification. EMBO (Eur. Mol. Biol. Organ.) J.
13:2305Ð2312.
Clague, M.J., S. Urbe, F. Aniento, and J. Gruenberg. 1994. Vacuolar ATPase
activity is required for endosomal carrier vesicle formation. J. Biol. Chem.
269:21Ð24.
Daro, E., D. Sheff, M. Gomez, T. Kreis, and I. Mellman. 1997. Inhibition of en-
dosome function in CHO cells bearing a temperature-sensitive defect in the
coatomer (COPI) component epsilon-COP. J. Cell Biol. 139:1747Ð1759.
De Camilli, P., K. Takei, and P.S. McPherson. 1995. The function of dynamin in
endocytosis. Curr. Opin. Neurobiol. 5:559Ð565.
Donaldson, J.G., D. Finazzi, and R.D. Klausner. 1992. Brefeldin A inhibits
Golgi membrane-catalysed exchange of guanine nucleotide onto ARF pro-
tein. Nature. 360:350Ð352.
Durrbach, A., D. Louvard, and E. Coudrier. 1996. Actin filaments facilitate two
steps of endocytosis. J. Cell Sci. 109:457Ð465.
Fishman, J.B., and R.E. Fine. 1987. A trans Golgi-derived exocytic coated vesi-
cle can contain both newly synthesized cholinesterase and internalized trans-
ferrin. Cell. 48:157Ð164.
Futter, C.E., A. Gibson, E.H. Allchin, S. Maxwell, L.J. Ruddock, G. Odorizzi,
D. Domingo, I.S. Trowbridge, and C.R. Hopkins. 1998. In polarized MDCK
cells basolateral vesicles arise from clathrin-gamma-adaptin-coated domains
on endosomal tubules. J. Cell Biol. 141:611Ð623.
Geuze, H.J., J.W. Slot, G.J. Strous, H.F. Lodish, and A.L. Schwartz. 1983. Intra-
cellular site of asialoglycoprotein receptor-ligand uncoupling: double-label
immunoelectron microscopy during receptor-mediated endocytosis. Cell. 32:
277Ð287.
Geuze, H.J., J.W. Slot, and A.L. Schwartz. 1987. Membranes of sorting or-
ganelles display lateral heterogeneity in receptor distribution. J. Cell Biol.
104:1715Ð1723.
Goud, B., C. Jouanne, and J.-C. Antoine. 1984. Reversible pinocytosis of horse-
radish peroxidase in lymphoid cells. Exp. Cell Res. 153:218Ð235.
Gruenberg, J., and F.R. Maxfield. 1995. Membrane transport in the endocytic
pathway. Curr. Opin. Cell Biol. 7:552Ð563.
Gu, F., F. Aniento, R.G. Parton, and J. Gruenberg. 1997. Functional dissection
of COP-I subunits in the biogenesis of multivesicular endosomes. J. Cell
Biol. 139:1183Ð1195.
Hansen, S.H., K. Sandvig, and B. van Deurs. 1992. Internalization efficiency of
the transferrin receptor. Exp. Cell Res. 199:19Ð28.
Helms, J.B., and J.E. Rothman. 1992. Inhibition by brefeldin A of a Golgi mem-
brane enzyme that catalyses exchange of guanine nucleotide bound to ARF.
Nature. 360:352Ð354.The Journal of Cell Biology, Volume 143, 1998 990
Humphrey, J.S., P.J. Peters, L.C. Yuan, and J.S. Bonifacino. 1993. Localization
of TGN38 to the trans-Golgi network: Involvement of a cytoplasmic ty-
rosine-containing sequence. J. Cell Biol. 120:1123Ð1135.
Hunziker, W., J.A. Whitney, and I. Mellman. 1991. Selective inhibition of trans-
cytosis by brefeldin A in MDCK cells. Cell. 67:617Ð627.
Hunziker, W., J.A. Whitney, and I. Mellman. 1992. Brefeldin A and the en-
docytic pathway. Possible implications for membrane traffic and sorting.
FEBS (Fed. Eur. Biochem. Soc.) Lett. 307:93Ð96.
Iacopetta, B.J., and E.H. Morgan. 1983. The kinetics of transferrin endocytosis
and iron uptake from transferrin in rabbit reticulocytes. J. Biol. Chem. 258:
9108Ð9115.
Jin, M., G. Sahagian, and M.D. Snider. 1989. Transport of surface mannose
6-phosphate receptor to the Golgi complex in cultured human cells. J. Biol.
Chem. 264:7675Ð7680.
Johannes, L., and B. Goud. 1998. Surfing on a retrograde wave: how does Shiga
toxin reach the endoplasmic reticulum? Trends Cell Biol. 8:158Ð162.
Johannes, L., D. Tenza, C. Antony, and B. Goud. 1997. Retrograde transport of
KDEL-bearing B-fragment of Shiga toxin. J. Biol. Chem. 272:19554Ð19561.
Kim, J.H., L. Johannes, B. Goud, C. Antony, C.A. Lingwood, R. Daneman, and
S. Grinstein. 1998. Nonivasive measurement of the pH of the endoplasmic
reticulum at rest and during calcium release. Proc. Natl. Acad. Sci. USA. 95:
2997Ð3002.
Klausner, R.D., J.G. Donaldson, and J. Lippincott-Schwartz. 1992. Brefeldin A:
Insights into the control of membrane traffic and organelle structure. J. Cell
Biol. 116:1071Ð1080.
Le Borgne, R., and B. Hoflack. 1997. Mannose 6-phosphate receptors regulate
the formation of clathrin-coated vesicles in the TGN. J. Cell Biol. 137:335Ð345.
Le Borgne, R., G. Griffiths, and B. Hoflack. 1996. Mannose 6-phosphate recep-
tors and ADP-ribosylation factors cooperate for high affinity interaction of the
AP-1 Golgi assembly proteins with membranes. J. Biol. Chem. 271:2162Ð2170.
Lingwood, C.A. 1993. Verotoxins and their glycolipid receptors. Adv. Lipid
Res. 25:189Ð211.
Lingwood, C.A. 1996. Role of verotoxin receptors in pathogenesis. Trends Mi-
crobiol. 4:147Ð153.
Lippincott-Schwartz, J., J.G. Donaldson, A. Schweizer, E.G. Berger, H.P.
Hauri, L.C. Yuan, and R.D. Klausner. 1990. Microtubule-dependent retro-
grade transport of proteins into the ER in the presence of brefeldin A sug-
gests an ER recycling pathway. Cell. 60:821Ð836.
Lippincott-Schwartz, J., L. Yuan, C. Tipper, M. Amherdt, L. Orci, and R.D.
Klausner. 1991. Brefeldin AÕs effects on endosomes, lysosomes, and the
TGN suggest a general mechanism for regulating organelle structure and
membrane traffic. Cell. 67:601Ð616.
Llorente, A., A. Rapak, S.L. Schmid, B. van Deurs, and K. Sandvig. 1998. Ex-
pression of mutant dynamin inhibits toxicity and transport of endocytosed ri-
cin to the Golgi apparatus. J. Cell Biol. 140:553Ð563.
Lombardi, D., T. Soldati, M.A. Riederer, Y. Goda, M. Zerial, and S.R. Pfeffer.
1993. Rab9 functions in transport between late endosomes and the trans
Golgi network. EMBO (Eur. Mol. Biol. Organ.) J. 12:677Ð682.
Louvard, D., C. Morris, G. Warren, K. Stanley, F. Winkler, and H. Reggio.
1983. A monoclonal antibody to the heavy chain of clathrin. EMBO (Eur.
Mol. Biol. Organ.) J. 2:1655Ð1664.
Matlin, K.S., and K. Simons. 1983. Reduced temperature prevents transfer of a
membrane glycoprotein to the cell surface but does not prevent terminal gly-
cosylation. Cell. 34:233Ð243.
Maxfield, F.R., and S. Mayor. 1997. Cell surface dynamics of GPI-anchored
proteins. Adv. Exp. Med. Biol. 419:355Ð364.
Mellman, I. 1996. Endocytosis and molecular sorting. Annu. Rev. Cell. Dev.
Biol. 12:575Ð625.
Miettinen, H.M., K. Matter, W. Hunziker, J.K. Rose, and I. Mellman. 1992. Fc
receptor endocytosis is controlled by a cytoplasmic domain determinant that
actively prevents coated pit localization. J. Cell Biol. 116:875Ð888.
Molloy, S.S., L. Thomas, J.K. VanSlyke, P.E. Stenberg, and G. Thomas. 1994.
Intracellular trafficking and activation of the furin proprotein convertase: lo-
calization to the TGN and recycling from the cell surface. EMBO (Eur. Mol.
Biol. Organ.) J. 13:18Ð33.
Mukherjee, S., R.N. Ghosh, and F.R. Maxfield. 1997. Endocytosis. Physiol.
Rev. 77:759Ð803.
Munier-Lehmann, H., F. Mauxion, and B. Hoflack. 1996. Function of the two
mannose 6-phosphate receptors in lysosomal enzyme transport. Biochem.
Soc. Trans. 24:133Ð136.
Nambiar, M.P., and H.C. Wu. 1995. Ilimaquinone inhibits the cytotoxicities of
ricin, diphtheria toxin, and other protein toxins in Vero cells. Exp. Cell Res.
219:671Ð678.
OÕBrien, A.D., V.L. Tesh, A. Donohue-Rolfe, M.P. Jackson, S. Olsnes, K.
Sandvig, A.A. Lindberg, and G.T. Keusch. 1992. Shiga toxin: biochemistry,
genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Im-
munol. 180:65Ð94.
Ohno, H., J. Stewart, M.C. Fournier, H. Bosshart, I. Rhee, S. Miyatake, T.
Saito, A. Gallusser, T. Kirchhausen, and J.S. Bonifacino. 1995. Interaction of
tyrosine-based sorting signals with clathrin-associated proteins. Science. 269:
1872Ð1875.
Pelham, H.R., L.M. Roberts, and J.M. Lord. 1992. Toxin entry: how reversible
is the secretory pathway? Trends Cell Biol. 2:183Ð185.
Ponnambalam, S., C. Rabouille, J.P. Luzio, T. Nilsson, and G. Warren. 1994.
The TGN38 glycoprotein contains two non-overlapping signals that mediate
localization to the trans-Golgi network. J. Cell Biol. 125:253Ð268.
Reaves, B., and G. Banting. 1994a. Vacuolar ATPase inactivation blocks recy-
cling to the trans-Golgi network from the plasma membrane. FEBS Lett.
345:61Ð66.
Reaves, B., and G. Banting. 1994b. Overexpression of TGN38/41 leads to mis-
localisation of gamma-adaptin. FEBS (Fed. Eur. Biochem. Soc.) Lett. 351:
448Ð456.
Reaves, B., M. Horn, and G. Banting. 1993. TGN38/41 recycles between the cell
surface and the TGN: brefeldin A affects its rate of return to the TGN. Mol.
Biol. Cell. 4:93Ð105.
Riederer, M.A., T. Soldati, A.D. Shapiro, J. Lin, and S.R. Pfeffer. 1994. Lyso-
some biogenesis requires Rab9 function and receptor recycling from endo-
somes to the trans-Golgi network. J. Cell Biol. 125:573Ð582.
Robinson, M.S., and T.E. Kreis. 1992. Recruitment of coat proteins onto Golgi
membranes in intact and permeabilized cells: effects of brefeldin A and G
protein activators. Cell. 69:129Ð138.
Rothman, J.E., and F.T. Wieland. 1996. Protein sorting by transport vesicles.
Science. 272:227Ð234.
Salamero, J., R. Le Borgne, C. Saudrais, B. Goud, and B. Hoflack. 1996. Ex-
pression of major histocompatibility complex class II molecules in HeLa
cells promotes the recruitment of AP-1 Golgi-specific assembly proteins on
Golgi membranes. J. Biol. Chem. 271:30318Ð30321.
Sandvig, K., and S. Olsnes. 1979. Effect of temperature on the uptake, excretion
and degradation of abrin and ricin by HeLa cells. Exp. Cell Res. 121:15Ð25.
Sandvig, K., and B. van Deurs. 1996. Endocytosis, intracellular transport, and
cytotoxic action of Shiga toxin and ricin. Physiol. Rev. 76:949Ð966.
Sandvig, K., S. Olsnes, J.E. Brown, O.W. Petersen, and B. van Deurs. 1989. En-
docytosis from coated pits of Shiga toxin: A glycolipid-binding protein from
Shigella dysenteriae 1. J. Cell Biol. 108:1331Ð1343.
Sandvig, K., O. Garred, K. Prydz, J.V. Kozlov, S.H. Hansen, and B. van Deurs.
1992. Retrograde transport of endocytosed Shiga toxin to the endoplasmic
reticulum. Nature. 358:510Ð512.
Sandvig, K., M. Ryd, O. Garred, E. Schweda, P.K. Holm, and B. van Deurs.
1994. Retrograde transport from the Golgi complex to the ER of both Shiga
toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and
cAMP. J. Cell Biol. 126:53Ð64.
Schagger, H., and G. von Jagow. 1987. Tricine-sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis for the separation of proteins in the range
from 1 to 100 kDa. Anal. Biochem. 166:368Ð379.
Schapiro, F., C.A. Lingwood, W. Furuya, and S. Grinstein. 1998. pH-indepen-
dent retrograde targeting of glycolipids to the Golgi complex. Am. J. Phys-
iol. Cell Physiol. 43:319Ð332.
Schekman, R., and L. Orci. 1996. Coat proteins and vesicle budding. Science.
271:1526Ð1533.
Simpson, J.C., C. Dascher, L.M. Roberts, J.M. Lord, and W.E. Balch. 1995. Ri-
cin cytotoxicity is sensitive to recycling between the endoplasmic reticulum
and the Golgi complex. J. Biol. Chem. 270:20078Ð20083.
Slot, J.W., H.J. Geuze, S. Gigengack, G.E. Lienhard, and D.E. James. 1991. Im-
muno-localization of the insulin regulatable glucose transporter in brown ad-
ipose tissue of the rat. J. Cell Biol. 113:123Ð135.
Stamnes, M.A., and J.E. Rothman. 1993. The binding of AP-1 clathrin adaptor
particles to Golgi membranes requires ADP-ribosylation factor, a small
GTP-binding protein. Cell. 73:999Ð1005.
Stoorvogel, W., H.J. Geuze, J.M. Griffith, and G.J. Strous. 1988. The pathways
of endocytosed transferrin and secretory protein are connected in the trans-
Golgi reticulum. J. Cell Biol. 106:1821Ð1829.
Stoorvogel, W., V. Oorschot, and H.J. Geuze. 1996. A novel class of clathrin-
coated vesicles budding from endosomes. J. Cell Biol. 132:21Ð33.
Strous, G.J., P. van Kerkhof, G. van Meer, S. Rijnboutt, and W. Stoorvogel.
1993. Differential effects of brefeldin A on transport of secretory and lysoso-
mal proteins. J. Biol. Chem. 268:2341Ð2347.
Takei, K., P.S. McPherson, S.L. Schmid, and P. De Camilli. 1995. Tubular mem-
brane invaginations coated by dynamin rings are induced by GTP-gamma S
in nerve terminals. Nature. 374:186Ð190.
Traub, L.M., J.A. Ostrom, and S. Kornfeld. 1993. Biochemical dissection of AP-1
recruitment onto Golgi membranes. J. Cell Biol. 123:561Ð573.
van der Ende, A., A. du Maine, A.L. Schwartz, and G.J. Strous. 1989. Effect of
ATP depletion and temperature on the transferrin-mediated uptake and re-
lease of iron by BeWo choriocarcinoma cells. Biochem. J. 259:685Ð692.
van Deurs, B., O.W. Petersen, S. Olsnes, and K. Sandvig. 1987. Delivery of in-
ternalized ricin from endosomes to cisternal Golgi elements is a discontinu-
ous, temperature-sensitive process. Exp. Cell Res. 171:137Ð152.
van Weert, A.W., K.W. Dunn, H.J. Gueze, F.R. Maxfield, and W. Stoorvogel.
1995. Transport from late endosomes to lysosomes, but not sorting of inte-
gral membrane proteins in endosomes, depends on the vacuolar proton
pump.  J. Cell Biol. 130:821Ð834.
von Figura, K. 1991. Molecular recognition and targeting of lysosomal proteins.
Curr. Opin. Cell Biol. 3:642Ð646.
Warnock, D.E., and S.L. Schmid. 1996. Dynamin GTPase, a force-generating
molecular switch. Bioessays. 18:885Ð893.
Whitney, J.A., M. Gomez, D. Sheff, T.E. Kreis, and I. Mellman. 1995. Cytoplas-
mic coat proteins involved in endosome function. Cell. 83:703Ð713.
Wood, S.A., J.E. Park, and W.J. Brown. 1991. Brefeldin A causes a microtu-
bule-mediated fusion of the trans-Golgi network and early endosomes. Cell.
67:591Ð600.